Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Our site is under planned maintenance. At this time, you will not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Confronting Cachexia - A Disease within a Disease

WEBINAR

Only

Confronting Cachexia - A Disease within a Disease

Friday, April 16, 2021, 10:00 AM - 5:00 PM EDT

Webinar

Presented By

The Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

 

Cachexia is a multifactorial and multi-organ syndrome that is one of the main causes of morbidity and mortality in late stages of chronic conditions such as cancer, acquired immune deficiency syndrome (AIDS), chronic obstructive pulmonary disease (COPD), heart failure, and chronic kidney disease (CKD). As such, cachexia is often referred to as “a disease within a disease”.

Cachexia is a wasting syndrome characterized by signs and symptoms that may include weight loss, anorexia, decreased muscle strength, increased fatigue, and abnormal biochemistry and increase of inflammatory markers. These changes have been associated with increased morbidity and mortality as well as reduced quality of life.

This virtual symposium will bring together researchers from academia and industry to discuss the latest advancements in studying cachexia as a distinct disorder uncovering how inflammation and metabolic imbalances drive its pathology.

Call for Abstracts

You are invited to submit an abstract to be considered for short talks and a virtual poster session. For submission instructions, please visit our online portal. The deadline for abstract submission is March 5, 2021.

Registration

Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Deadline:
6
days
left

Scientific Organizing Committee

Bei B. Zhang, PhD

Pfizer

Antonio Filareto, PhD

Boehringer Ingelheim

Marcus Goncalves, MD, PhD

Weill Cornell Medicine

Sonya Dougal, PhD

The New York Academy of Sciences

Barbara Knappmeyer

The New York Academy of Sciences

Keynote Speaker

Daniel Marks, MD, PhD

Oregon Health Sciences University

Speakers

Vickie Baracos, PhD

University of Alberta

Morris Birnbaum, MD, PhD

Pfizer

Jeffrey Crawford, MD

Duke University School of Medicine

Dr. Maria Rohm

Helmholtz Center, Munich

Marcus Goncalves, MD, PhD

Weill Cornell Medicine

Event Support

Friday

April 16, 2021

10:00 AM

Welcome Remarks

10:05 AM

Keynote Address: Cross Talks Between Brain and Periphery in Cancer Cachexia

Speaker

Daniel Marks, MD
Oregon Health Sciences University

Session 1: New Frontiers in Disease Understanding

10:50 AM

Radiological Criteria to Quantify Catabolic Losses in Patient with Cancer

Speaker

Vicki Baracos, PhD
Univ. Alberta, Canada
11:20 AM

A Clinical Algorithm to Manage Patients with Cachexia

Speaker

Marcus Goncalves, MD, PhD
Weill Cornell Medicine
11:50 AM

Lunch Break

Session 2: Delineating Underlying Biological Pathways

12:20 PM

Tissue Crosstalk in Cancer Metabolism

Speaker

Maria Rohm, PhD
Helmholtz Institute Munich
12:50 PM

Gut Microbiota and Cachexia

Speaker

Laure Bindels, PhD
Louvain Drug Research Institute, Belgium
1:20 PM

Break

1:30 PM

NF-kB Signaling and Skeletal Muscle Wasting in Cancer Cachexia

Speaker

Denis Guttridge, PhD
Medical University of South Carolina
2:00 PM

The Role of Signaling by the Activin and IL-6 Family in Cachexia

Speaker

Teresa Zimmers, PhD
Indiana University
2:30 PM

Short talk 1 to be Selected from Abstracts

2:45 PM

Short talk 2 to be Selected from Abstracts

3:00 PM

Poster Session / Networking Break (30 min)

Session 3: Approaches Targeting Therapeutic Intervention

3:30 PM

Cachexia as a Metabolic Disease – Novel Transformative Therapies

Speaker

Morris Birnbaum, MD, PhD
Pfizer
4:00 PM

Clinical trials in cancer cachexia: challenges and opportunities

Speaker

Jeffrey Crawford
Duke University School of Medicine
4:30 PM

Targeted Nutrition Interventions for the Prevention and Treatment of Cachexia

Speaker

Carla Prado, PhD
University of Alberta
5:00 PM

Adjourn